Cuvestrequin™ Price Reduction: Now £33.50 This Summer

As horses spend more time at pasture this summer, everyday skin injuries (grazes, cuts, and abrasions) become a...

Live Webinar: Have Stem Cells in Equine Medicine Stood the Test of Time?

25 Years of Equine Regenerative Medicine — An Honest Panel Discussion Twenty-five years ago, stem cell therapy entered...

Live Webinar: Equine OA Is a Progressive Disease. Your Management Plan Should Progress With It.

A free clinical webinar exploring stage-aware musculoskeletal management in equine osteoarthritis. This session presents a sequential treatment framework...

Nupsala Supply Update: Planning Ahead in Changing Global Logistics Conditions

At Nupsala, we believe in keeping our customers informed about developments that may influence supply chains and delivery...

Nupsala: A Veterinary Wholesaler That Reinvests in the Profession

The veterinary sector is changing. New discount resellers are entering the market — businesses whose sole strategy is...

Nupsala hosts VOA lecture sessions at LVS 

Dear Colleague, Nupsala are excited to announce that they are working closely with the Veterinary Osteoarthritis Association (VOA)...

Management of Adverse Reactions Following Intra-Articular Injections in Equine Patients

1. General Principles Adverse reactions following intra-articular (IA) injections are uncommon but can occur with any injectable product...

Intibio A2MG Kit: Raising the Standard Beyond Current Orthobiologics

Recent findings from Zoetis, in collaboration with the University of Pennsylvania New Bolton Center, have highlighted the comparative...

Nupsala Launches StrideSpin Flex™ – A Breakthrough Centrifuge Platform for Veterinary Practices

Nupsala announced the launch of the StrideSpin Flex™ Centrifuge, designed to streamline veterinary orthobiologics and laboratory workflow. For...

Nupsala’s Summer Half Day BBQ – Celebrating a Year of Wins ☀️

After a busy year of innovation, collaboration and progress, it was time to take a well-earned break and...

Pioneering A2M Technology: Nupsala Introduces Intibio’s Advanced Processing Kit to the UK

Nupsala is proud to announce the launch of the Intibio A2M (Alpha-2-Macroglobulin) processing kit, now available exclusively in...

Nupsala Reaffirms Commitment to Veterinary Choice and Innovation in the Equine A2M Market

For the past four years, Nupsala has proudly partnered with Astaria to provide equine veterinarians across the United...

Nupsala Hosts Successful Intra-Articular CPD Session at Harper Adams University

Nupsala recently held a highly successful Intra-Articular CPD session at Harper Adams University, welcoming veterinary professionals from across...

Nupsala is an Endometriosis Friendly Employer!

Nupsala has signed up to become an Endometriosis Friendly Employer, helping drive positive change in the workplace for...

Celebrating Nupsala EU – Walking to Romania Challenge

Walking to Romania: Celebrating Nupsala EU and a Milestone Achievement Earlier this year, we launched the Walking to Romania...

Everything worth knowing in equine MSK, straight to your inbox.

By signing up to this newsletter, you consent to Nupsala UK contacting you by email with clinical newsletters, product updates, and event invitations. You can withdraw your consent at any time by unsubscribing or contacting us directly. See our Privacy Policy for more information on how we handle your data.

Nupsala Supply Update

Global logistics conditions are currently evolving and may lead to occasional changes in shipping timelines or transportation costs in the coming months.

Our operations continue as normal, but we recommend planning orders slightly in advance where possible and considering combining shipments to maximise efficiency.

©Copyright Nupsala 2024

Created & Powered by Codesky